Transcription-dependent degradation of topoisomerase I-DNA covalent complexes

Molecular and Cellular Biology

Volumn 23, Issue 7, 2003, Pages 2341-2350

  Desai, Shyamal D ^a   Zhang, Hui ^b   Rodriguez Bauman, Alexandra ^a   Yang, Jin Ming ^c   Wu, Xiaohua ^c   Gounder, Murugesan K ^c   Rubin, Eric H ^c   Liu, Leroy F ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DNA TOPOISOMERASE; RNA; RNA POLYMERASE;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA TRANSCRIPTION; ENZYME DEGRADATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; TRANSCRIPTION TERMINATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CELL LINE; CRICETINAE; DNA; DNA REPAIR; DNA TOPOISOMERASES, TYPE I, EUKARYOTIC; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; HAPLORHINI; HUMANS; LUNG; LYMPHOCYTES; MACROMOLECULAR SUBSTANCES; MICE; MICE, NUDE; NEOPLASMS; NUCLEIC ACID SYNTHESIS INHIBITORS; PEPTIDE HYDROLASES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN SUBUNITS; RNA POLYMERASE II; SIGNAL TRANSDUCTION; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; TOPOTECAN; TRANSCRIPTION, GENETIC; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ANIMALIA;

EID: 0037378557     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.7.2341-2350.2003     Document Type: Article

References (38)

1. Andoh, T., K. Ishii, Y. Suzuki, Y. Ikegami, Y. Kusunoki, Y. Takemoto, and K. Okada. 1987. Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I. Proc. Natl. Acad. Sci. USA 84:5565-5569.
2. Baskaran, R., G. G. Chiang, T. Mysliwiec, G. D. Kruh, and J. Y. Wang. 1997. Tyrosine phosphorylation of RNA polymerase II carboxyl-terminal domain by the Abl-related gene product. J. Biol. Chem. 272:18905-18909.
3. Bendixen, C., B. Thomsen, J. Alsner, and O. Westergaard. 1990. Camptothecin-stabilized topoisomerase I-DNA adducts cause premature termination of transcription. Biochemistry 29:5613-5619.
4. Bregman, D. B., R. Halaban, A. J. van Gool, K. A. Henning, E. C. Friedberg, and S. L. Warren. 1996. UV-induced ubiquitination of RNA polymerase II: a novel modification deficient in Cockayne syndrome cells. Proc. Natl. Acad. Sci. USA 93:11586-11590.
5. Chen, A. Y., and L. F. Liu. 1994. DNA topoisomerases: essential enzymes and lethal targets. Annu. Rev. Pharmacol. Toxicol. 34:191-218.
6. D'Arpa, P., C. Beardmore, and L. F. Liu. 1990. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons. Cancer Res. 50:6919-6924.
7. Davis, P. L., W. L. Shaiu, G. L. Scott, J. D. Iglehart, T. S. Hsieh, and J. R. Marks. 1998. Complex response of breast epithelial cell lines to topoisomerase inhibitors. Anticancer Res. 18:2919-2932.
8. Desai, S. D., T. K. Li, A. Rodriguez-Bauman, E. H. Rubin, and L. F. Liu. 2001. Ubiquitin/26S proteasome-mediated degradation of topoisomerase I as a resistance mechanism to camptothecin in tumor cells. Cancer Res. 61:5926-5932.
9. Desai, S. D., L. F. Liu, D. Vazquez-Abad, and P. D'Arpa. 1997. Ubiquitin-dependent destruction of topoisomerase I is stimulated by the antitumor drug camptothecin. J. Biol. Chem. 272:24159-24164.
10. Haluska, P., Jr., A. Saleem, Z. Rasheed, F. Ahmed, E. W. Su, L. F. Liu, and E. H. Rubin. 1999. Interaction between human topoisomerase I and a novel RING finger/arginine-serine protein. Nucleic Acids Res. 27:2538-2544.
11. Hochster, H., L. Liebes, J. Speyer, J. Sorich, B. Taubes, R. Oratz, J. Wernz, A. Chachoua, R. H. Blum, and A. Zeleniuch-Jacquotte. 1997. Effect of prolonged topotecan infusion on topoisomerase 1 levels: a phase I and pharmacodynamic study. Clin. Cancer Res. 3:1245-1252.
12. Hsiang, Y. H., R. Hertzberg, S. Hecht, and L. F. Liu. 1985. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J. Biol. Chem. 260:14873-14878.
13. Hsiang, Y. H., M. G. Lihou, and L. F. Liu. 1989. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res. 49:5077-5082.
14. Larsen, A. K., and C. Gobert. 1999. DNA topoisomerase I in oncology: Dr Jekyll or Mr Hyde? Pathol. Oncol. Res. 5:171-178.
15. Li, L. H., T. J. Fraser, E. J. Olin, and B. K. Bhuyan. 1972. Action of camptothecin on mammalian cells in culture. Cancer Res. 32:2643-2650.
16. Li, T. K., and L. F. Liu. 2001. Tumor cell death induced by topoisomerase-targeting drugs. Annu. Rev. Pharmacol. Toxicol. 41:53-77.
17. Liu, L. F. 1989. DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem. 58:351-375.
18. Ljungman, M., and P. C. Hanawalt. 1996. The anti-cancer drug camptothecin inhibits elongation but stimulates initiation of RNA polymerase II transcription. Carcinogenesis 17:31-35.
19. Mao, Y., S. D. Desai, C. Y. Ting, J. Hwang, and L. F. Liu. 2001. 26 S proteasome-mediated degradation of topoisomerase II cleavable complexes. J. Biol. Chem. 276:40652-40658.
20. Mao, Y., M. Sun, S. D. Desai, and L. F. Liu. 2000. SUMO-1 conjugation to topoisomerase I: a possible repair response to topoisomerase-mediated DNA damage. Proc. Natl. Acad. Sci. USA 97:4046-4051.
21. Nitiss, J. L., and J. C. Wang. 1996. Mechanisms of cell killing by drugs that trap covalent complexes between DNA topoisomerases and DNA. Mol. Pharmacol. 50:1095-1102.
22. Pommier, Y., G. Kohlhagen, P. Pourquier, J. M. Sayer, H. Kroth, and D. M. Jerina. 2000. Benzo[a]pyrene diol epoxide adducts in DNA are potent suppressors of a normal topoisomerase I cleavage site and powerful inducers of other topoisomerase I cleavages. Proc. Natl. Acad. Sci. USA 97:2040-2045.
23. Porter, S. E., and J. J. Champoux. 1989. The basis for camptothecin enhancement of DNA breakage by eukaryotic topoisomerase I. Nucleic Acids Res. 17:8521-8532.
24. Pouliot, J. J., C. A. Robertson, and H. A. Nash. 2001. Pathways for repair of topoisomerase I covalent complexes in Saccharomyces cerevisiae. Genes Cells 6:677-687.
25. Rasheed, Z. A., A. Saleem, Y. Ravee, P. P. Pandolfi, and E. H. Rubin. 2002. The topoisomerase I-binding RING protein, topors, is associated with promyelocytic leukemia nuclear bodies. Exp. Cell Res. 277:152-160.
26. Ratner, J. N., B. Balasubramanian, J. Corden, S. L. Warren, and D. B. Bregman. 1998. Ultraviolet radiation-induced ubiquitination and proteasomal degradation of the large subunit of RNA polymerase II. Implications for transcription-coupled DNA repair. J. Biol. Chem. 273:5184-5189.
27. Rosing, H., D. M. van Zomeren, E. Doyle, W. W. ten Bokkel, J. H. Schellens, A. Bult, and J. H. Beijnen. 1999. Quantification of topotecan and its metabolite N-desmethyltopotecan in human plasma, urine and faeces by high-performance liquid chromatographic methods. J. Chromatogr. B 727:191-203.
28. Rubin, E., V. Wood, A. Bharti, D. Trites, C. Lynch, S. Hurwitz, S. Bartel, S. Levy, A. Rosowsky, D. Toppmeyer, and D. Kufe. 1995. A phase I and pharmacokinetic study of a new camptothecin derivative, 9-aminocamptothecin. Clin. Cancer Res. 1:269-276.
29. Shao, R. G., C. X. Cao, H. Zhang, K. W. Kohn, M. S. Wold, and Y. Pommier. 1999. Replication-mediated DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA: DNA-PK complexes. EMBO J. 18:1397-1406.
30. Squires, S., A. J. Ryan, H. L. Strutt, and R. T. Johnson. 1993. Hypersensitivity of Cockayne's syndrome cells to camptothecin is associated with the generation of abnormally high levels of double strand breaks in nascent DNA. Cancer Res. 53:2012-2019.
31. Subramanian, D., C. S. Furbee, and M. T. Muller. 2001. ICE bioassay. Isolating in vivo complexes of enzyme to DNA. Methods Mol. Biol. 95:137=147.
32. Subramanian, D., B. S. Rosenstein, and M. T. Muller. 1998. Ultraviolet-induced DNA damage stimulates topoisomerase I-DNA complex formation in vivo: possible relationship with DNA repair. Cancer Res. 58:976-984.
33. Takashima, H., C. F. Boerkoel, J. John, G. M. Saifi, M. A. Salih, D. Armstrong, Y. Mao, F. A. Quiocho, B. B. Roa, M. Nakagawa, D. W. Stockton, and J. R. Lupski. 2002. Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy. Nat. Genet. 32:267-272.
34. Vance, J. R., and T. E. Wilson. 2002. Yeast Tdp1 and Rad1-Rad10 function as redundant pathways for repairing Top1 replicative damage. Proc. Natl. Acad. Sci. USA 99:13669-13674.
35. Woudstra, E. C., C. Gilbert, J. Fellows, L. Jansen, J. Brouwer, H. Erdjument-Bromage, P. Tempst, and J. Q. Svejstrup. 2002. A Rad26-Def1 complex coordinates repair and RNA pol II proteolysis in response to DNA damage. Nature 415:929-933.
36. Wu, J., and L. F. Liu. 1997. Processing of topoisomerase I cleavable complexes into DNA damage by transcription. Nucleic Acids Res. 25:4181-4186.
37. Wu, R. S., A. Kumar, and J. R. Warner. 1971. Ribosome formation is blocked by camptothecin, a reversible inhibitor of RNA synthesis Proc. Natl. Acad. Sci. USA 68:3009-3014.
38. Zhang, H., J. C. Wang, and L. F. Liu. 1988. Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes. Proc. Natl. Acad. Sci. USA 85:1060-1064.